Alterations in ornithine decarboxylase activity in the rat mammary gland after different periods of 50 Hz magnetic field exposure

Bioelectromagnetics

Volumn 20, Issue 6, 1999, Pages 338-346

  Mevissen, Meike ^a   Häußler, Monika ^a   Löscher, Wolfgang ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Breast cancer; Electromagnetic fields; Melatonin; ODC; Proliferation

Indexed keywords

AMINO ACIDS; CARCINOGENS; CELL PROLIFERATION; ELECTROMAGNETIC FIELDS; HORMONES; MAGNETIC FIELDS; STEM CELLS; TUMORS;

BREAST CANCER; EFFECT OF MAGNETIC FIELD; FIELD EXPOSURE; MAGNETIC-FIELD; MAMMARY GLAND; MAMMARY TUMORS; MELATONIN; ORNITHINE DECARBOXYLASE; PROLIFERATION; SPRAGUE-DAWLEY RATS;

RATS;

7,12 DIMETHYLBENZ[A]ANTHRACENE; CARCINOGEN; MELATONIN; ORNITHINE DECARBOXYLASE; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL; ARTICLE; CELL DIVISION; COCARCINOGENESIS; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; FEMALE; HISTOLOGY; MAGNETISM; METABOLISM; RAT; SPRAGUE DAWLEY RAT; UDDER;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CELL DIVISION; COCARCINOGENESIS; FEMALE; MAGNETICS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MELATONIN; ORNITHINE DECARBOXYLASE; RATS; RATS, SPRAGUE-DAWLEY; TETRADECANOYLPHORBOL ACETATE;

EID: 0033194614     PISSN: 01978462     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-186X(199909)20:6<338::AID-BEM2>3.0.CO;2-J     Document Type: Article

References (37)

1. Bates MN. 1991. Extremely low frequency electromagnetic fields and cancer: the epidemiologic evidence. Environ Health Perspect 95: 147-156.
2. Baum A, Mevissen M, Kamino K, Mohr U, Löscher W. 1995. A histopathological study on alterations in DMBA-induced mammary carcinogenesis in rats with 50 Hz, 100 μT magnetic field exposure. Carcinogenesis 16:119-125.
3. 14C-carboxyl-labeled amino acids. Anal Biochem 84:638-641.
4. Boorman GA, Wilson JT, van Zwieten MJ, Eustis SL. 1990. Mammary gland. In: Boorman GA, Eustis SL, Elwell MR, Montgomery CA, Mackenzie WF. editors. Pathology of the Fischer rat. San Diego: Academic Press, p 295-314.
5. Byus CV, Pieper SE, Adey WR. 1987. The effects of low-energy 60 Hz environmental electromagnetic fields upon the growth-related enzyme ornithine decarboxylase. Carcinogenesis 8:1385-1389.
6. Cain CD, Salvador EQ, Adey WR. 1988. 60 Hz electric field prolongs ornithine decarboxylase activity response to 12-O-tetradecanoylphorbol-13-acetate (TPA) in C3H10T1/2 fibroblasts. Abstracts of the Bio-electromagnetics Society, 10th Annual Meeting, Stamford, CT, p 3.
7. Feychting M. 1996. Occupational exposure to electromagnetic fields and adult leukaemia: a review of the epidemiological evidence. Radiat Environ Biophys 35:237-242.
8. Fozard JR, Prakash NJ. 1982. Effects of DL-O-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, on the rat mammary tumour induced by 7,12-dimethylbenz[a]anthracene. Naunyn Schmiedebergs Arch Pharmacol 320:72-77.
9. Hebel R, Stromberg MW. 1986. Anatomy and embryology of the laboratory rat. BioMed Wörthsee.
10. Hendee WR, Boteler JC. 1994. The question of health effects from exposure to electromagnetic fields. Health Phys 66:127-136.
11. Kumlin T, Alhonen L, Jänne J, Lang S, Kosma V-M, Juutilainen J. 1998. Epidermal ornithine decarboxylase and polyamines in mice exposed to 50 Hz magnetic fields and UV radiation. Bioelectromagnetics 19:388-391.
12. Li CY, Theriault G, Lin RS. 1996. Epidemiological appraisal of studies of residential exposure to power frequency magnetic fields and adult cancers. Occup Environ Med 53:505-510.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
14. Löscher W, Liburdy RP. 1998. Animal and cellular studies on carcinogenic effects of low frequency. 50/60 Hz. magnetic fields. Mutat Res 410:185-220.
15. Löscher W, Mevissen M. 1994. Animal studies on the role of 50/60 Hertz magnetic fields in carcinogenesis. Life Sci 54:1531-1543.
16. Löscher W, Mevissen M. 1997. Magnetic fields and breast cancer: Experimental studies on the melatonin hypothesis. In: Stevens RG, Wilson BW, Anderson LE, editors. The melatonin hypothesis: breast cancer and use of electric power. Columbus: Battelle Press, p. 555-584.
17. Löscher W, Mevissen M, Lehmacher W, Stamm A. 1993. Tumor promotion in a breast cancer model by exposure to a weak alternating magnetic field. Cancer Lett 71:75-81.
18. Luk GD, Hamilton SR, Yang P, Smith JA, O'Ceallaigh D, McAvinchey D, Hyland J. 1986. Kinetic changes in mucosal ornithine decarboxylase activity during azoxymethane-induced colonie carcinogenesis in the rat. Cancer Res 46:4449-4452.
19. Meinert R, Michaelis J. 1996. Meta analyses of studies on the association between electromagnetic fields and childhood cancer. Radiat Environ Biophys 35:11-18.
20. Mevissen M, Kietzmann M, Löscher W. 1995. In vivo exposure of rats to a weak alternating magnetic field increases ornithine decarboxylase activity in the mammary gland by a similar extent as the carcinogen DMBA. Cancer Lett 90:207-214.
21. Mevissen M, Häussler M, Szamel M, Emmendörffer A, Thun-Battersby S, Löscher W. 1998a. Complex effects of long-term 50 Hz magnetic field exposure in vivo on immune functions in female Sprague-Dawley rats. Bioelectromagnetics 19:259-270.
22. Mevissen M, Häußler M, Lerchl A, Löscher W. 1998b. Acceleration of mammary tumorigenesis by exposure of 7,12-dimethylbenz[a]anthracene-treated female rats in a 50 Hz, 100 μT magnetic field: replication study. J Toxicol Environ Health 53:401-418.
23. O'Brien TG. 1976. The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Res 36:2644-2653.
24. O'Brien TG, Simsiman RC, Boutwell RK. 1975. Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res 35:1662-167C.
25. Russell DH. 1980. Ornithine decarboxylase as a biological and pharmacological tool. Pharmacology 20:117-129.
26. Russo IH, Russo J. 1996a. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 104:938-967.
27. Russo J, Russo IH. 1996b. Experimentally iiduced mammary tumors in rats. Breast Cancer Res Treat 39:7-20.
28. Russo J, Saby J, Isenberg WM, Russo IH. 1977. Pathogenesis of mammary carcinoma induced in rats by 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 59:435-445.
29. Savitz DA. 1995. Overview of occupational exposure to electric and magnetic fields and cancer: advancements in exposure assessment. Environ Health Perspect 103:69-74.
30. Savitz DA, Ahlbom A. 1994. Epidemiologic evidence on cancer in relation to residential and occupational exposures. In: Carpenter DO, Ayrapetyan S, editors. Biological effects of electric and magnetic fields. San Diego: Academic Press, p. 233-261.
31. Selmaoui B, Touitou Y. 1995. Sinusoidal 50 Hz magnetic fields depress rat pineal NAT activity and serum melatonin. Role of duration and intensity of exposure. Life Sci 57:1351-1358.
32. Stevens RG. 1987. Electric power use and breast cancer: a hypothesis. Am J Epidemiol 125:556-561.
33. Stevens RG. 1993. Biologically based epidemiological studies of electric power and cancer. Environ Health Perspect 101(Suppl 4):93-100.
34. Sumiyoshi H, Baer AR, Wargovitch MJ. 1991. Heterogenicity of ornithine decarboxylase during mouse colon carcinogenesis and in human colon tumors. Cancer Res 51:2069-2072.
35. Szmigielski S. 1993. Electromagnetic fields and neoplasms with special reference to extremely low frequencies. Bioelectrochem Bioenerg 30:1-3 (Abstract).
36. Torgersen O. 1975. Regional distribution of DMBA-induced mammary tumours in the rat. Acta Pathathol Microbiol Scand 83:639-644.
37. van Zwieten MJ. 1984. The rat as animal model in breast cancer research. Boston: Martinus Nijhoff.